These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 11085539)

  • 21. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
    Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.
    Uchinokura S; Miyata S; Fukushima T; Itoh H; Nakano S; Wakisaka S; Kataoka H
    Int J Cancer; 2006 Feb; 118(3):583-92. PubMed ID: 16106403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein.
    Kawaguchi M; Orikawa H; Baba T; Fukushima T; Kataoka H
    FEBS J; 2009 Jul; 276(13):3481-90. PubMed ID: 19456860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues.
    Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Shimomura T
    Exp Neurol; 1998 Sep; 153(1):60-4. PubMed ID: 9743567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES; Menicucci G; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
    EXS; 1993; 65():311-28. PubMed ID: 8380739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells.
    Moriyama T; Kataoka H; Hamasuna R; Yokogami K; Uehara H; Kawano H; Goya T; Tsubouchi H; Koono M; Wakisaka S
    Biochem Biophys Res Commun; 1998 Aug; 249(1):73-7. PubMed ID: 9705834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
    Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.
    Itoh H; Kataoka H
    J Gastroenterol; 2002 Nov; 37 Suppl 14():15-21. PubMed ID: 12572861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hepatocyte growth factor regulatory factors in human breast cancer.
    Parr C; Watkins G; Mansel RE; Jiang WG
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
    Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatocyte growth factor (HGF) and its therapeutic applications].
    Segura-Flores AA; Gálvez-Gastélum FJ; Alvarez-Rodríguez A; Armendáriz-Borunda J
    Rev Gastroenterol Mex; 2004; 69(4):243-50. PubMed ID: 15765978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.
    Yang XM; Park M
    Lab Invest; 1995 Oct; 73(4):483-91. PubMed ID: 7474919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
    Di Renzo MF; Olivero M; Giacomini A; Porte H; Chastre E; Mirossay L; Nordlinger B; Bretti S; Bottardi S; Giordano S
    Clin Cancer Res; 1995 Feb; 1(2):147-54. PubMed ID: 9815967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells.
    Tsao MS; Zhu H; Giaid A; Viallet J; Nakamura T; Park M
    Cell Growth Differ; 1993 Jul; 4(7):571-9. PubMed ID: 8398897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.